+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Evaluation of colistin as an agent against multi-resistant Gram-negative bacteria

Evaluation of colistin as an agent against multi-resistant Gram-negative bacteria

International Journal of Antimicrobial Agents 25(1): 11-25

Infections caused by multi-resistant Gram-negative bacteria, particularly Pseudomonas aeruginosa, are increasing worldwide. In patients with cystic fibrosis (CF), resistance in P. aeruginosa to numerous anti-pseudomonal agents is becoming common. The absence since 1995, of new substances active against resistant Gram-negative bacteria, has caused increasing concern. Colistin, an old antibiotic also known as polymyxin E, has attracted more interest recently because of its significant activity against multi-resistant P. aeruginosa, Acinetobacter baumannii and Klebsiella pneumoniae, and the low resistance rates to it. Because its use as an anti-pseudomonal agent was displaced by the potentially less toxic aminoglycosides in 1970s, our knowledge of this drug is limited. However, there has been a significant recent increase in the data gathered on colistin, focussing on its chemistry, antibacterial activity, mechanism of action and resistance, pharmacokinetics, pharmacodynamics and new clinical application. It is likely that colistin will be an important antimicrobial option against multi-resistant Gram-negative bacteria, for some years to come.

(PDF emailed within 0-6 h: $19.90)

Accession: 048995425

Download citation: RISBibTeXText

PMID: 15620821

DOI: 10.1016/j.ijantimicag.2004.10.001

Related references

Activity of the colistin-rifampicin combination against colistin-resistant, carbapenemase-producing Gram-negative bacteria. Journal of ChemoTherapy 26(4): 211-216, 2015

Intrathecal/intraventricular colistin in external ventricular device-related infections by multi-drug resistant Gram negative bacteria: case reports and review. Infection 42(5): 801-809, 2015

Efflux pump inhibitor CCCP to rescue colistin susceptibility in mcr-1 plasmid-mediated colistin-resistant strains and Gram-negative bacteria. Journal of Antimicrobial ChemoTherapy 2018, 2018

Colistin alone versus colistin plus meropenem for treatment of severe infections caused by carbapenem-resistant Gram-negative bacteria: an open-label, randomised controlled trial. Lancet. Infectious Diseases 18(4): 391-400, 2018

Comparison of E-test and disc diffusion methods for the in vitro evaluation of the antimicrobial activity of colistin in multi-drug resistant Gram-negative Bacilli. Saudi Medical Journal 31(5): 507-511, 2010

Norfloxacin: a new oral chemotherapeutic agent effective against multi-drug-resistant Gram-negative bacteria and cocci. Rational directions for treatment. Giornale Italiano di Chemioterapia 31(1-2): 65-71, 1984

Susceptibility of Colistin-Resistant, Gram-Negative Bacteria to Antimicrobial Peptides and Ceragenins. Antimicrobial Agents and ChemoTherapy 61(8), 2017

Use of colistin in treating multi-resistant Gram-negative organisms in a specialised burns unit. Burns 36(4): 522-527, 2010

Tryptamine derivatives disarm colistin resistance in polymyxin-resistant gram-negative bacteria. Bioorganic and Medicinal Chemistry 2019, 2019

SuperPolymyxinâ„¢ Medium for the Screening of Colistin-Resistant Gram-Negative Bacteria in Stool Samples. Frontiers in Microbiology 9: 2809, 2018

Colonization and infection by colistin-resistant Gram-negative bacteria in a cohort of critically ill patients. Clinical Microbiology and Infection 17(11): E9-E11, 2012

Effects of Efflux Pump Inhibitors on Colistin Resistance in Multidrug-Resistant Gram-Negative Bacteria. Antimicrobial Agents and ChemoTherapy 60(5): 3215-3218, 2017

Intravenous colistin sulphomethate sodium for therapy of infections due to multidrug-resistant gram-negative bacteria. Journal of Infection 56(3): 185-190, 2008

Capillary electrophoresis for fast detection of heterogeneous population in colistin-resistant Gram-negative bacteria. Electrophoresis 36(20): 2630-2633, 2016

A traceless reversible polymeric colistin prodrug to combat multidrug-resistant (MDR) gram-negative bacteria. Journal of Controlled Release 259: 83-91, 2017